140 related articles for article (PubMed ID: 22631672)
1. Early efficacy of Endostar combined with chemoradiotherapy for advanced cervical cancers.
Ke QH; Zhou SQ; Huang M; Lei Y; Du W; Yang JY
Asian Pac J Cancer Prev; 2012; 13(3):923-6. PubMed ID: 22631672
[TBL] [Abstract][Full Text] [Related]
2. Intensity-modulated radiation therapy (IMRT)-based concurrent chemoradiotherapy (CCRT) with Endostar in patients with pelvic locoregional recurrence of cervical cancer: Results from a hospital in the Qinghai-Tibet Plateau.
Zhang K; Wang H; Wang Z; Li F; Cui Y; Ma S; Chen R; Wang Y; Guo S; Wei Y
Medicine (Baltimore); 2020 Dec; 99(49):e21966. PubMed ID: 33285664
[TBL] [Abstract][Full Text] [Related]
3. Endostar improved efficacy of concurrent chemoradiotherapy with vinorelbine plus carboplatin in locally advanced lung squamous cell carcinoma patients with high serum Lp(a) concentration.
Xu H; Lv D; Meng Y; Wang M; Wang W; Zhou C; Zhou S; Chen X; Yang H
Ann Palliat Med; 2020 Mar; 9(2):298-307. PubMed ID: 32075401
[TBL] [Abstract][Full Text] [Related]
4. Endostar, an Antiangiogenesis Inhibitor, Combined With Chemoradiotherapy for Locally Advanced Cervical Cancer.
Lu H; Wu Y; Liu X; Huang H; Jiang H; Zhu C; Man Y; Chen Z; Long X; Pang Q; Peng L; Li X; Gu J; Deng S; Xing L
Oncol Res; 2022 Jan; 28(9):929-944. PubMed ID: 34544526
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of endostar combined with chemoradiotherapy versus chemoradiotherapy alone in locally advanced cervical cancer: A PRISMA-compliant systematic review and meta-analysis.
Maimaitiming N; Ma X; Wei Y; Cao L; Gao Y; Zhang L
Medicine (Baltimore); 2022 Sep; 101(36):e30170. PubMed ID: 36086700
[TBL] [Abstract][Full Text] [Related]
6. Early efficacy of taxotere and cisplatin chemo-radiotherapy for advanced cervical cancer.
Ke QH; Zhou SQ; Du W; Lei Y; Huang M; Luo F; Yang JY
Asian Pac J Cancer Prev; 2012; 13(2):617-9. PubMed ID: 22524834
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].
Li XF; Li YH; Gao YN; Li CL; Yue HZ; Xu G; Li DM; Su X
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):763-7. PubMed ID: 24406134
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of the initial efficacy of nedaplatin combined with megestrol in concurrent chemoradiotherapy for advanced cervical cancer].
Ke QH; Zhou SQ; Su XY; Liu Z; Zhang WT; Yang JY
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):629-31. PubMed ID: 22325227
[TBL] [Abstract][Full Text] [Related]
9. A Randomized Controlled Trial Comparing Clinical Outcomes and Toxicity of Lobaplatin- Versus Cisplatin-Based Concurrent Chemotherapy Plus Radiotherapy and High-Dose-Rate Brachytherapy for FIGO Stage II and III Cervical Cancer.
Wang JQ; Wang T; Shi F; Yang YY; Su J; Chai YL; Liu Z
Asian Pac J Cancer Prev; 2015; 16(14):5957-61. PubMed ID: 26320479
[TBL] [Abstract][Full Text] [Related]
10. APJ Is Associated with Treatment Response in Gastric Cancer Patients Receiving Concurrent Chemoradiotherapy and Endostar Therapy.
Hao YZ; Li ML; Ning FL; Wang XW
Cancer Biother Radiopharm; 2017 May; 32(4):133-138. PubMed ID: 28514205
[TBL] [Abstract][Full Text] [Related]
11. Endostar (rh-endostatin) versus placebo in combination with vinorelbine plus cisplatin chemotherapy regimen in treatment of advanced non-small cell lung cancer: A meta-analysis.
An J; Lv W
Thorac Cancer; 2018 May; 9(5):606-612. PubMed ID: 29575575
[TBL] [Abstract][Full Text] [Related]
12. Phase 2 trial of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced cervical cancer.
Nogueira-Rodrigues A; Moralez G; Grazziotin R; Carmo CC; Small IA; Alves FV; Mamede M; Erlich F; Viegas C; Triginelli SA; Ferreira CG
Cancer; 2014 Apr; 120(8):1187-93. PubMed ID: 24615735
[TBL] [Abstract][Full Text] [Related]
13. Concurrent paclitaxel/cisplatin chemoradiotherapy with or without consolidation chemotherapy in high-risk early-stage cervical cancer patients following radical hysterectomy: preliminary results of a phase III randomized study.
Zhao H; Li L; Su H; Lin B; Zhang X; Xue S; Fei Z; Zhao L; Pan Q; Jin X; Xie C
Oncotarget; 2016 Oct; 7(43):70969-70978. PubMed ID: 27391158
[TBL] [Abstract][Full Text] [Related]
14. [Clinical results of recombinant human endostatin combined with chemoradiotherapy for locally advanced nasopharyngeal carcinoma].
Li Y; Jin F; Wu W; Long J; Gong X; Chen G; Bi T; Li Z; He Q; Ma F; Wang R
Zhonghua Zhong Liu Za Zhi; 2015 Feb; 37(2):128-32. PubMed ID: 25975690
[TBL] [Abstract][Full Text] [Related]
15. [A multicenter, randomized, double-blind, placebo-controlled safety study to evaluate the clinical effects and quality of life of paclitaxel-carboplatin (PC) alone or combined with endostar for advanced non-small cell lung cancer (NSCLC)].
Han BH; Xiu QY; Wang HM; Shen J; Gu AQ; Luo Y; Bai CX; Guo SL; Liu WC; Zhuang ZX; Zhang Y; Zhao YZ; Jiang LY; Shi CL; Jin B; Zhou JY; Jin XQ
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):854-9. PubMed ID: 22335953
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of bevacizumab in combination with definitive radiotherapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma: preliminary results of RTOG 0417.
Schefter TE; Winter K; Kwon JS; Stuhr K; Balaraj K; Yaremko BP; Small W; Gaffney DK
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1179-84. PubMed ID: 22342094
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of the combination of endostar with chemotherapy on stage IVb and recurrent metastatic cervical cancer.
Guo F; Chen C; Liang Y; Ma S; Zou W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 45(12):1412-1418. PubMed ID: 33472996
[TBL] [Abstract][Full Text] [Related]
18. Endostar combined with chemotherapy for treatment of metastatic colorectal and gastric cancer: a pilot study.
Zhou JF; Bai CM; Wang YZ; Li XY; Cheng YJ; Chen SC
Chin Med J (Engl); 2011 Dec; 124(24):4299-303. PubMed ID: 22340403
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of endostar combined with chemotherapy in multi-cycle treatment of patients with advanced non-small cell lung cancer].
Li N; Jin ZL; Liu ZJ; Wang J; Li K
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):937-42. PubMed ID: 22340106
[TBL] [Abstract][Full Text] [Related]
20. A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of paclitaxel-carboplatin alone or with endostar for advanced non-small cell lung cancer.
Han B; Xiu Q; Wang H; Shen J; Gu A; Luo Y; Bai C; Guo S; Liu W; Zhuang Z; Zhang Y; Zhao Y; Jiang L; Zhou J; Jin X
J Thorac Oncol; 2011 Jun; 6(6):1104-9. PubMed ID: 21532504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
